Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  News  >  Business Leaders  >  Business Leaders Biography

Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance ProfessionalsCalendarSectors 
HomeAll newsMost read newsBusiness Leaders Biography
Portrait de Mikael Dolsten MD, PhD
Age : 59
Public asset : 14,113,977 USD
Linked companies : Pfizer Inc. - Karyopharm Therapeutics Inc
Summary 
Mikael Dolsten is on the board of New York Academy of Sciences, Karyopharm Therapeutics, Inc. and PhRMA Foundation and Member of Royal Swedish Academy of Engineering Sciences, Member of Government-University-Industry Research Roundtable and President-Worldwide Research & Development at Pfizer Inc.

In his past career Mikael Dolsten was Principal at OrbiMed Advisors LLC and Partner at OrbiMed Advisors Private Equity (a subsidiary of OrbiMed Advisors LLC), President of Wyeth Research, EVP, Global Head-Pharma Research & Discovery at Boehringer Ingelheim Pharmaceuticals, Inc., Member-Benefits, Law & Regulatory Committee at Wyeth Pharmaceuticals LLC and Senior Vice President of Wyeth Corp.

Dr. Dolsten received a doctorate from the University of Lund.


Current positions of Mikael Dolsten MD, PhD 
NameTitle Since
Karyopharm Therapeutics Inc
(Biotechnology & Medical Research)
Independent Director 2015
New York Academy of Sciences Member-Governors Board -
PhRMA Foundation Director -
Pfizer Inc.
(Pharmaceuticals)
President-Worldwide Research & Development 2009
Royal Swedish Academy of Engineering Sciences Member -
Government-University-Industry Research Roundtable Member -


Holdings of Mikael Dolsten MD, PhD 
NameEquities%Valuation
Pfizer (PFE)
Pharmaceuticals
339,9320.0058%14,113,977 USD
Karyopharm Therapeutics Inc (KPTI)
Biotechnology & Medical Research
00.0000%0 USD


Mikael Dolsten MD, PhD: Personal Network 


Most Read News 
09/18JOHN TYSON : Tyson Foods CEO steps down for personal reasons
RE
09/18JACK MA : Alibaba's Jack Ma says U.S.-China trade friction could last 20 years
RE
09/17ELON MUSK : Musk
RE
09/16JAMIE DIMON : JP Morgan chief Dimon says shouldn't have made remarks about Trump
RE
09/17JACK MA : Top Company News of the Day
DJ
04:55aJACK MA : Xinhua
RE
09/14SERGIO MARCHIONNE : The home of Fiat says 'ciao' to Sergio Marchionne
RE
09/17JAMIE DIMON : How JPMorgan's CFO became the top prospect to succeed Dimon
RE
09/14JACK MA : Xiaomi creates new management jobs aimed at CEO succession planning
RE
09/14JEFF BEZOS : Amazon's Jeff Bezos commits $2 billion to help homeless, pre-schools
RE
More news


© 2018 People and Ownership :   
Advertisement
Mikael Dolsten MD, PhD : Connections 
Delphi Ventures III LP
Relypsa, Inc.
Vicarious Surgical, Inc.
Delphi Ventures, Inc.
San Francisco Conservatory of Music
Delphi Management Partners VII LLC
National Venture Capital Association



Popular Business Leaders 
Marc Benioff Jeff Bezos Vincent Bolloré Martin Bouygues Warren Buffett Tim Cook Elmar Degenhart Michael Dell Oleg Deripaska Jamie Dimon Jack Dorsey Nicandro Durante John Edwards Bill Gates Carlos Ghosn James Gorman David Henry Heinrich Hiesinger Carl Icahn Charles Koch Brian Krzanich Ulrich Lehner Richard Li Daniel Loeb Jack Ma Sergio Marchionne Leslie Moonves Dennis Muilenburg Rupert Murdoch Elon Musk Peter Nicholas Xavier Niel Indra Nooyi John Paulson Thomas Rabe Sumner Redstone Alexandre Ricard Wilbur Ross Charles Schwab Severin Schwan Masayoshi Son Martin Sorrell Rupert Stadler Tidjane Thiam Patrick Thomas François Villeroy De Galhau Martin Winterkorn Dieter Zetsche Mark Zuckerberg
A-Z Business Leaders